7BXA
Crystal structure of PD-1 in complex with tislelizumab Fab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 5C (4A) |
Synchrotron site | PAL/PLS |
Beamline | 5C (4A) |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2019-05-08 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 1 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.615, 73.081, 276.388 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 48.407 - 3.320 |
R-factor | 0.2456 |
Rwork | 0.243 |
R-free | 0.29860 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4ky1 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHENIX |
Refinement software | PHENIX (1.13_2998) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 3.410 |
High resolution limit [Å] | 3.320 | 3.320 |
Number of reflections | 19822 | 985 |
<I/σ(I)> | 2 | |
Completeness [%] | 99.3 | |
Redundancy | 4.5 | |
CC(1/2) | 0.947 | 0.788 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.2 M ammonium sulfate, 30% w/v polyethylene glycol 4000 |